Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Immuunrespons SARS-CoV-2 bij Lifelines-deelnemers
nov 2020 | Pneumonie, Virale infecties